chronic prostatitis/chronic pelvic pain syndrome(CP/cPPS)
Conditions
Interventions
cotrol group:1.tamsulosin 0.2mg/d+placebo
2.the course of treatment
experiment group:1.tolterodine 4mg/d+tamsulosin 0.2mg/d
Sponsors
Fuling Central Hospital, Chongqing, China
Eligibility
Sex/Gender
Male
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. a diagnosis of CP/CPPS based on the classification of US National Institutes of Health, aged 18-45 yr; 2. a total score of at least 12 on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI); 3. a urinary score of at least 3 on the CPSI; 4. subjects who anticipate improving symptoms; 5. the course of disease is over half one year.
Exclusion criteria
Exclusion criteria: 1. previous treatment with any other alpha-adrenergic receptor blocker and antimuscarinic agents for symptoms of CP/CPPS or for any other reason; 2. those who had had previous urinary tract infection with the last year; 3. those who had been treat or were taking medication that could affect lower urinary tract function; 4. those who met the criteria for chronic bacterial prostatitis after lower urinary tract localization studies; 5. those who had other significant medical problems; 6. PSA is over 4ng/ml; 7. those who had glaucoma; 8. those who had been treated with lower urinary tract operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the pain score of CPSI;the QOL score of CPSI;total CPSI score;the voiding score of CPS; | — |
Secondary
| Measure | Time frame |
|---|---|
| International Index of Erectile Function;peak urinary flow rate;EPS examination; | — |
Countries
China
Contacts
Public ContactChen Yong
Outcome results
None listed